novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56⁺ cells for its action
MacDonald, A.J, Libri, N.A, Lustigman, S, Barker, S.J, Whelan, M.A, Semper, A.E, Rosenberg, W.M
Published in Clinical and experimental immunology (01.05.2008)
Published in Clinical and experimental immunology (01.05.2008)
Get full text
Journal Article